Big Pharma poured billions into AI drug discovery. It could soon pay off

Eli Lilly is eyeing an off-ramp for patients to switch from weight loss injections to pills

A federal panel picked by RFK Jr. voted to end Hepatitis B vaccines for newborns

'There's never been a drug with this range': The weight loss boom is just getting started

Ozempic is getting cheaper as Novo Nordisk rushes to undercut Eli Lilly

Ozempic is coming to Thanksgiving

1 in 5 U.S. adults say they've taken Ozempic or similar drugs, survey finds

Eli Lilly and Novo Nordisk cut deals with Trump to lower weight loss drug prices

Soaring drug prices are leaving inflation in the dust

Trump says Ozempic will get much cheaper. Novo Nordisk and Eli Lilly shares tumble

Wegovy and Zepbound should be the go-to obesity treatment, medical group says

Health insurers say they'll keep covering vaccines as a political fight widens

Trump's ongoing battle with the pharma industry shows no signs of easing

RFK Jr. takes aim at court that protects vaccine makers from lawsuits

WHO adds GLP-1 weight loss drugs to list of the world's essential medicines for the first time

Corporate healthcare costs could soon see their biggest increase in a decade

FDA biologics chief back 12 days after resigning, creating pressure on biotech stocks

Eli Lilly and Novo Nordisk whipsawed by Wall Street's ever-rising hopes for weight loss drugs

Novo Nordisk posts disappointing earnings as fierce Ozempic competition hits hard

Turmoil at the FDA means uncertainty for innovative new drugs

More stories